Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Large DFS Benefit from Adjuvant Cemiplimab Among Patients at High Risk...

Ogkologos - 18 Ιουνίου, 2025

French Senate Committee Backs ESMO Call to Revise EU Regulation to...

Ogkologos - 17 Ιουνίου, 2025

Structured Exercise Programme Initiated Soon After the Completion of Adjuvant Chemotherapy...

Ogkologos - 17 Ιουνίου, 2025

Tarlatamab Prolongs OS Over Chemotherapy Among Patients with SCLC Whose Disease...

Ogkologos - 16 Ιουνίου, 2025

ESMO Announces Results of 2025 Elections

Ogkologos - 14 Ιουνίου, 2025

FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC with High...

Ogkologos - 13 Ιουνίου, 2025

EMA Recommends Extension of Therapeutic Indications for Brentuximab Vedotin

Ogkologos - 12 Ιουνίου, 2025

ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act

Ogkologos - 11 Ιουνίου, 2025

Elinzanetant Leads To a Significantly Lower Frequency of Vasomotor Symptoms Associated...

Ogkologos - 11 Ιουνίου, 2025

ESMO Calls for Cancer to Be at the Core of the...

Ogkologos - 10 Ιουνίου, 2025

1...474849...440 Σελίδα 48 από 440

MOST POPULAR

ESMO Highlights Key Issues for Patients with Cancer and Their Carers...

27 Μαΐου, 2025

Undetectable MRD and Extended PFS More Common with MRD-guided Ibrutinib-Venetoclax than...

13 Οκτωβρίου, 2025

Higher Rates of Metastasis-Free Survival in Men with High-Risk Non-Metastatic Prostate...

11 Ιανουαρίου, 2022

Lucky 13-A Male Breast Cancer Story

20 Οκτωβρίου, 2021

Φόρτωση περισσοτέρων

Large DFS Benefit from Adjuvant Cemiplimab Among Patients at High Risk...

French Senate Committee Backs ESMO Call to Revise EU Regulation to...

Structured Exercise Programme Initiated Soon After the Completion of Adjuvant Chemotherapy...

Tarlatamab Prolongs OS Over Chemotherapy Among Patients with SCLC Whose Disease...

ESMO Announces Results of 2025 Elections

FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC with High...

EMA Recommends Extension of Therapeutic Indications for Brentuximab Vedotin

ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act

Elinzanetant Leads To a Significantly Lower Frequency of Vasomotor Symptoms Associated...

ESMO Calls for Cancer to Be at the Core of the...

MOST POPULAR

ESMO Highlights Key Issues for Patients with Cancer and Their Carers...

Undetectable MRD and Extended PFS More Common with MRD-guided Ibrutinib-Venetoclax than...

Higher Rates of Metastasis-Free Survival in Men with High-Risk Non-Metastatic Prostate...

Lucky 13-A Male Breast Cancer Story

HOT NEWS

Bean there done that: Can swapping to pulses be the new...

An unexpected find: clues about the genetics of children’s cancer found...

Adjuvant fractionated radiotherapy significantly improves DFS in patients with atypical meningioma...

An Important Part of Cancer Caregiving That’s Often Overlooked and How...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ